Homepage | Thorax
WEBThorax is a Plan S compliant Transformative Journal.. Thorax is one of the world's leading respiratory medicine journals, publishing clinical and experimental research articles on respiratory medicine, paediatrics, immunology, pharmacology, pathology, and surgery.Thorax seeks to publish significant advances in scientific understanding, which are likely to impact on clinical practice.
Current Issue | Thorax
WEBAug 6, 2024 · Nicklas Brustad, Jonathan Thorsen, Casper Emil Tingskov Pedersen, Mina Ali, Julie Kyvsgaard, Sarah Brandt, Jenni Lehtimäki, Nicole Prince, Nilofar V Følsgaard, Jessica Lasky-Su, Jakob Stokholm, Klaus Bønnelykke, Bo Chawes. Original research: Environmental exposures associated with early childhood …
Authors | Thorax
WEBAuthors. Thorax is one of the world’s leading respiratory medicine journals, publishing clinical and experimental research articles on respiratory medicine, paediatrics, immunology, pharmacology, pathology, and surgery. Thorax seeks to publish significant advances in scientific understanding, which are likely to impact on clinical practice.
About - Thorax
WEBThorax is one of the world's leading respiratory medicine journals, publishing clinical and experimental research articles on respiratory medicine, critical care, paediatrics, immunology, pharmacology, pathology, and surgery. Thorax seeks to publish significant advances in scientific understanding, which are likely to impact on clinical practice.
British Thoracic Society Guideline for pleural disease | Thorax
WEBJul 1, 2023 · Since the last British Thoracic Society (BTS) Guideline for pleural disease published in 2010, 3–9 many high-quality and practice changing studies, using patient-centred outcomes, have been published. The paradigms for the investigation and management of pleural disease have therefore shifted.
Long-term impact of ivacaftor on mortality rate and health …
WEBBackground Ivacaftor (IVA) has been shown to improve lung function and other clinical outcomes in people with cystic fibrosis (CF). A decade of real-world IVA availability has enabled the examination of long-term outcomes with this treatment. This retrospective, longitudinal cohort study investigated the impact of IVA on mortality rate and health outcomes among people with CF in the US.
Ambulatory treatment in the management of pneumothorax: a systematic ...
WEBIntroduction Spontaneous pneumothorax (SP) is broken down into primary (PSP: no known underlying lung disease), secondary (SSP: known lung disease) and from trauma or iatrogenic pneumothorax (IP). Current treatments include a conservative approach, needle aspiration, chest drain, suction and surgery. A Heimlich valve (HV) is a lightweight one-way valve designed for the ambulatory treatment of ...
British Thoracic Society Guideline for pleural disease | Thorax
WEBThe following is a summary of the British Thoracic Society (BTS) Guideline for pleural disease and includes a summary of the guideline recommendations and good practice points (GPPs). The full guideline is published as a separate Thorax Supplement1 and is available from the BTS website.2 Please refer to the full guideline for full information about each section.1 All online supplemental ...
Management of spontaneous pneumothorax: British Thoracic …
WEBThe term ‘pneumothorax’ was first coined by Itard and then Laennec in 1803 and 1819 respectively,1 and refers to air in the pleural cavity (ie, interspersed between the lung and the chest wall). At that time, most cases of pneumothorax were secondary to tuberculosis, although some were recognised as occurring in otherwise healthy patients (‘pneumothorax simple’). This classification ...
Table of contents | Thorax
WEBAug 19, 2022 · Chronic obstructive pulmonary disease. Environmental exposure. Paediatric lung disease. Respiratory epidemiology. Respiratory infection. Tuberculosis. State of the art review. Brief communication. Images in Thorax.
Skip to content